S&P 500 Industrials Sector SEC Filings — April 30, 2026

30-04-2026

Altos Ventures Management, Inc. filed a 13F-HR report on April 30, 2026, for the quarter ended March 31, 2026, disclosing that it holds no Section 13(f) securities. The report confirms zero holdings across all categories.

• ·Business address: 250 California Dr, Floor 4, Burlingame, CA 94010
• ·Phone: (650) 234-9771
• ·SEC file number: 028-22167
• ·CIK: 0001881755

30-04-2026

Sentage Holdings Inc. (SNTG) filed its 20-F Annual Report on April 30, 2026. The excerpt discusses U.S. federal income tax considerations for holders of its Ordinary Shares, defining U.S. persons (including certain corporations, trusts, and substantial shareholders) and outlining Passive Foreign Investment Company (PFIC) status criteria based on passive income (75% threshold) or assets (50% threshold). It details taxation of excess distributions or gains, allocated ratably over the holding period and treated as ordinary income for prior non-PFIC years.

30-04-2026

Emergent BioSolutions reported Q1 2026 total revenues of $156.1 million, down 30% YoY from $222.2 million, driven by sharp declines in Anthrax MCM revenues (55% to $21.6 million) and Smallpox MCM (40% to $64.2 million), with Naloxone down 5% to $42.9 million partially offset by Other Products surging to $16.0 million. Net income plummeted 90% to $6.8 million and Adjusted EBITDA fell 55% to $35.6 million, though the company secured over $221.5 million in new government contracts, refinanced debt with a $150 million facility, and authorized $50 million in share repurchases. Strategic moves include new manufacturing partnerships with SAB Biotherapeutics and Substipharm Biologics, alongside product launches and approvals.

• ·Capital expenditures decreased 33% to $2.4 million.
• ·R&D expenses down 30% to $10.5 million.
• ·SG&A expenses down 11% to $46.6 million.
• ·Appointed John D. Fowler, Jr. to Board of Directors.
• ·Resolution of New York Attorney General investigation related to legacy claims.
• ·Approval from Singapore Health Sciences Authority for expanded indication of ACAM2000® to include mpox.

30-04-2026

Pioneer Bancorp reported first quarter 2026 net income of $5.3 million ($0.22 per share), down from $5.8 million ($0.23 per share) YoY, driven by noninterest expenses rising 24.2% to $18.1 million due to higher professional fees, salaries, and litigation costs. However, net interest income increased 8.7% YoY to $20.8 million with net interest margin expanding 9 basis points to 4.21%, supported by loan growth of 3.3% QoQ to $1.70 billion and deposits up 6.5% QoQ to $1.85 billion. The company completed acquisitions of Targeted Lending ($140 million enterprise value, $120 million loans), Reiser Consulting Group, and Wyndham Benefits to bolster specialty financing and employee benefits divisions.

• ·Non-performing assets declined to $9.0 million (0.40% of total assets) at March 31, 2026 from $11.3 million (0.52%) at December 31, 2025.
• ·Allowance for credit losses on loans was $26.0 million (1.51% of total loans) at March 31, 2026.
• ·Estimated uninsured deposits, net of affiliate and collateralized, were 14.4% of total deposits at March 31, 2026.
• ·Tier 1 (leverage) capital to average assets ratio of 11.56% at March 31, 2026, above well-capitalized standard.
• ·Effective tax rate decreased to 7.3% in Q1 2026 from 22.3% in Q1 2025 due to discrete tax item.

30-04-2026

NorthEast Community Bancorp reported net income of $10.0 million for the three months ended March 31, 2026, down 5.7% from $10.6 million in the prior year period, with net interest income declining 0.5% YoY to $24.1 million and net interest margin contracting 2.4% to 4.99%. Total assets decreased 1.9% QoQ to $2.0 billion, and net loans fell 1.7% QoQ to $1.8 billion, though deposits edged up 0.6% QoQ to $1.6 billion. Positively, asset quality remained flawless with no non-performing loans, construction loan commitments rose 37.8% YoY with $819 million in unfunded commitments (up 20.6% QoQ), and performance metrics included ROA of 1.97% and ROE of 11.13%.

• ·Loan originations totaled $266.1 million in Q1 2026, primarily $244.2 million in construction loans.
• ·No credit loss expense recorded in Q1 2026 vs. $237,000 in Q1 2025.
• ·Charge-offs of $27,000 in Q1 2026 vs. $117,000 in Q1 2025.
• ·NOW/money market accounts increased 16.5% QoQ, offsetting declines in certificates of deposit down 6.3% QoQ.
• ·Borrowings decreased 71.4% QoQ to $20.0 million.

30-04-2026

Southside Bancshares reported Q1 2026 net income of $23.3 million, up 8.1% YoY from $21.5 million, with diluted EPS of $0.78 (up 9.9%) and linked quarter loan growth of 2.7% to $4.95 billion. Net interest income rose to $57.7 million (up 7.1% YoY and 0.8% linked), with tax-equivalent NIM expanding 3bps linked to 3.01%, while nonperforming assets fell sharply to 0.11% of total assets. However, noninterest expense increased 9.4% YoY and 8.3% linked quarter to $40.6 million, deposits grew only 0.1% linked quarter amid declines in retail (-1.6%) and public fund deposits (-1.7%), and efficiency ratio worsened to 56.44% from 53.85% linked quarter.

• ·Provision for credit losses on loans: $1.0 million in Q1 2026 (vs $0.6 million in Q4 2025)
• ·Q1 cash dividend: $0.36 per share, paid March 5, 2026
• ·No common stock repurchases under the Plan in Q1 2026; 0.8 million shares remain authorized
• ·Estimated uninsured deposits: 38.4% of total deposits (21.9% excluding affiliate and public fund deposits)
• ·Noninterest-bearing deposits: 20.0% of total deposits

30-04-2026

Lantern Pharma Inc. (LTRN) filed a 10-K/A on April 30, 2026, amending disclosures on beneficial ownership of common stock by directors, executive officers, and greater than 5% shareholders, with footnotes detailing exercisable options and direct holdings. Key 5% holders include entities associated with Bios Equity Partners aggregating approximately 836,752 shares, Garden City entity with 631,195 shares, and Mr. Satterfield-related entities with 570,000 shares. The amendment also updates Item 13 on related transactions thresholds and lists exhibits including equity incentive plans, employment agreements for executives like Panna Sharma and David Margrave, and license agreements.

• ·Bios Equity Entities aggregate: 249,037 (Bios Fund I) + 145,672 (Bios Fund I QP) + 287,442 (Bios Fund II QP) + 88,029 (Bios Fund II) + 38,479 (Bios Fund II NT) + 26,093 (Bios Directors) shares, per Schedule 13D/A filed April 16, 2026.
• ·Related transactions disclosure threshold: lesser of $120,000 or 1% of average total assets at year-end for last two fiscal years.
• ·Mr. Satterfield holdings breakdown: 95,000 (personal) + 45,000 (Tomsat) + 250,000 (Caldwell Mill) + 150,000 (A.G. Family L.P.) + 30,000 (Satterfield Vintage Investments) shares.

30-04-2026

Mechanics Bancorp reported Q1 2026 net income of $44.1 million ($0.19 per diluted share), down significantly from $111.2 million ($0.48 per diluted share) in Q4 2025 due to the absence of a $55.1 million bargain purchase gain, higher $7.8 million provision for credit losses driven by geopolitical uncertainty, and $4.8 million in merger-related costs. Total assets declined to $21.4 billion, loans to $13.9 billion, and deposits to $18.2 billion QoQ amid repayments and deposit maturities; however, net interest margin expanded to 3.61% from 3.50%, cost of deposits fell to 1.28% from 1.43%, and credit quality improved with delinquent loans dropping to 0.56% of total loans. Capital ratios remained strong with CET1 at 13.91%, though slightly down from 14.09% QoQ.

• ·Provision for credit losses $7.8 million in Q1 2026 vs reversal of $3.2 million in Q4 2025, including $6.5 million related to geopolitical uncertainty.
• ·Noninterest-bearing deposits $6.5 billion (36% of total deposits) at March 31, 2026, down from $6.7 billion (35%) at Dec 31, 2025.
• ·Loans-to-deposits ratio 76% at March 31, 2026, up from 75% at Dec 31, 2025.
• ·Book value per share $12.61 at March 31, 2026, down from $12.93 at Dec 31, 2025; tangible book value per share $7.53, down from $7.81.

30-04-2026

Newmark Group, Inc. reported Q1 2026 total revenues of $846.5 million, up 27.2% YoY from $665.5 million, driven by 21.2% growth in Management Services, Servicing Fees, and Other to $344.0 million, 20.2% in Leasing to $250.0 million, and a record 45.5% in Capital Markets to $252.5 million. GAAP EPS surged 260% to $0.08 from ($0.05), Adjusted EPS rose 57.1% to $0.33, and Adjusted EBITDA increased 35.8% to $121.2 million; however, compensation expenses rose 29.3% to $515.4 million and non-compensation expenses increased 13.7% to $197.9 million, reflecting higher revenues and growth investments. The company raised its full-year outlook, amended its credit facility to $900 million, repurchased 10.4 million shares, and declared a $0.06 per share dividend.

• ·Servicing and Asset Management portfolio reached a record $222.1 billion, up 19.2% YoY.
• ·Net leverage stood at 1.0 times as of March 31, 2026.
• ·Quarterly dividend increased to $0.06 per share, payable May 29, 2026.
• ·Fully diluted weighted-average share count for Adjusted Earnings stable at 256.0 million, up 0.3% YoY.

30-04-2026

Pilgrim's Pride Corporation filed an 8-K on April 30, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, attaching Exhibit 99.1 as supplemental historical financial information and an overview to be used during the Q1 2026 earnings conference call on April 30, 2026. The information is not deemed 'filed' for purposes of Section 18 of the Exchange Act. No specific financial metrics or period-over-period comparisons are disclosed in the filing text itself.

• ·Event date: April 29, 2026
• ·Earnings conference call scheduled for April 30, 2026
• ·Securities: Common Stock, Par Value $0.01 (PPC on Nasdaq Stock Market LLC)

30-04-2026

Demars Financial Group, LLC filed its Form 13F-HR on April 30, 2026, disclosing equity holdings as of March 31, 2026, primarily consisting of sole discretionary positions in a diversified portfolio of individual stocks and ETFs. Key holdings include Apple Inc., Berkshire Hathaway Inc. Del Cl B, BWX Technologies Inc., Chubb Ltd., and various iShares and SPDR ETFs. No prior period comparisons or performance metrics are provided in the filing.

• ·Filing CIK: 0001723115
• ·State of Incorporation: WA
• ·Business Address: 420 N EVERGREEN RD, STE 300, SPOKANE VALLEY, WA 99216
• ·All positions reported as SOLE investment discretion

30-04-2026

Phillip Street Middle Market Lending Fund LLC filed a Certificate of Amendment to its Certificate of Formation, changing its name to Phillip Street BDC LLC, executed on April 24, 2026. The original Certificate of Formation was filed on July 13, 2022, with the Delaware Secretary of State. The amendment was signed by Stanley Matuszewski, Chief Financial Officer.

• ·Filed under SEC 8-K Items 5.03 and 9.01 on April 30, 2026

30-04-2026

First Northern Community Bancorp reported first quarter 2026 net income of $5.9 million ($0.36 per diluted share), up 60.9% YoY from $3.7 million ($0.22 per diluted share), fueled by net interest income growth of 7.91% to $17.2 million, non-interest income up 19.75% to $1.7 million, and non-interest expense down 4.81% to $11.0 million. Total assets reached $1.92 billion (up 2.6% YoY), net loans $1.06 billion (up 2.3% YoY, driven by commercial but offset by declines in CRE, agriculture, residential, and consumer), and deposits $1.69 billion (up 1.2% YoY); however, QoQ net income declined 1.2% to $5.9 million from $6.0 million, net interest income fell 3.0%, and cash equivalents dropped 4.1%. The company issued a 5% stock dividend, announced a repurchase of up to 6% of shares, and uplisted to Nasdaq Capital Market post-quarter.

• ·ROAA 1.24% (up YoY from 0.79%, flat QoQ from 1.23%)
• ·ROAE 11.21% (down QoQ from 11.40%, up YoY from 8.23%)
• ·Total risk-based capital ratio exceeds 10%, with Total capital ratio 19.1%
• ·Book value per share $13.03 (up from $12.92 at Dec 31 2025 and $11.25 at Mar 31 2025)
• ·Provision for credit losses $300k (vs $850k YoY and reversal of $850k QoQ)
• ·Cost of funds 0.90% (up slightly YoY from 0.86%)

30-04-2026

Lipe & Dalton filed a 13F-HR on April 30, 2026, disclosing $191.04 million in total equity holdings across 92 positions as of March 31, 2026, all held on a sole discretionary basis. Top holdings include Apple Inc. at $16.643 million (65,579 shares), Goldman Sachs Group Inc. at $12.132 million (14,340 shares), and Brookfield Corp Cl A at $6.825 million (168,636 shares). No period-over-period changes or performance metrics are provided in the filing.

• ·Filing covers holdings as of 03-31-2026 with no other voting authority or shared discretion positions.
• ·Firm address: 103 East Water Street, Suite 305, Syracuse, NY 13202.

30-04-2026

Bausch Health Companies Inc. reported Q1 2026 revenues of $2,524 up 11.7% YoY from $2,259, primarily driven by product sales growth of 12.3% to $2,500. However, a $1,426 goodwill impairment resulted in an operating loss of $950 versus prior year income of $276, and net loss attributable to the company widened to $1,423 from $58. Cash provided by operating activities edged up 9% to $230 while total assets declined to $24,498 from $26,366 at year-end.

• ·Goodwill decreased to $9,807 from $11,271 at Dec 31 2025 due to $1,426 impairment.
• ·Shareholders' deficit widened to $(2,059) from $(554) at Dec 31 2025.
• ·Long-term debt (current + non-current) totaled $20,764 at Mar 31 2026 versus $20,817 at Dec 31 2025.
• ·Small acquisition with $87 fair value of consideration transferred and $65 identifiable net assets.

30-04-2026

Alphabet Inc. reported Q1 2026 revenues of $109,896M, up 21.8% YoY from $90,234M, with net income surging 81.1% YoY to $62,578M driven by strong Google Cloud growth of 63.4% to $20,028M and Google advertising up 15.5% to $77,253M. However, Google Network revenues declined 3.9% YoY to $6,971M, Other Bets fell 8.7% to $411M, and the company recorded hedging losses of $180M versus gains of $260M prior year. Total assets expanded to $703,919M, bolstered by acquisitions totaling $33,621M net.

• ·Operating cash flow increased 26.7% YoY to $45,790M.
• ·No stock repurchases in Q1 2026 versus $15,068M in Q1 2025.
• ·Long-term debt rose to $77,501M from $46,547M as of Dec 31, 2025.
• ·Goodwill increased to $57,774M from $33,380M, reflecting acquisitions.
• ·Dividends declared at $0.21 per share, up from $0.20 prior year.
• ·Net cash used in investing activities widened to $63,389M from $16,194M.

30-04-2026

Archimedes Tech SPAC Partners II Co. (ATII) filed a Form 425 on April 30, 2026, furnishing a transcript of a conference call held on April 28, 2026, where management teams from Forge Nano, Inc. and ATII reviewed their proposed business combination under a Merger Agreement dated April 20, 2026. The filing emphasizes that additional details will be in an upcoming Form S-4 Registration Statement and highlights extensive risks including shareholder approval failure, high redemptions, operational disruptions, and competitive pressures that could prevent closing or realization of benefits. Investors are urged to review SEC filings for complete information.

• ·Merger Agreement dated April 20, 2026, involving ATII, Pubco, Merger Sub I, Merger Sub II, and Forge Nano.
• ·ATII's Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed March 4, 2026.
• ·Securities: ATIIU (Units), ATII (Ordinary Shares), ATIIW (Warrants) on Nasdaq.

30-04-2026

River Road Asset Management, LLC filed a 13F-HR reporting total holdings valued at $8,828,138,271 across 176 positions as of March 31, 2026. Top holdings include BJ's Wholesale Club Holdings ($344,811,813), White Mountains Insurance Group ($264,775,422), McGrath RentCorp ($238,297,104), Murphy USA ($195,505,422), and GXO Logistics ($183,608,161). This quarterly snapshot provides no period-over-period comparisons or performance metrics.

• ·Filing date: April 30, 2026
• ·Report period end: March 31, 2026
• ·Form type: 13F-HR (combination report)
• ·Business address: 462 South Fourth Street, Suite 2000, Louisville, KY 40202

30-04-2026

ALPHA PRO TECH, LTD. filed a DEFA14A Definitive Additional Materials proxy statement on April 30, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required and is categorized as Definitive Additional Materials. No substantive proposals, financial data, or voting matters are detailed in the provided filing header.

• ·Filing Type: DEFA14A (Schedule 14A)
• ·Subcategory: Proxy Statement
• ·Payment of Filing Fee: No fee required

30-04-2026

Prosperity Bancshares announced its merger with Stellar Bancorp on January 28, 2026, with all regulatory approvals received and closure expected on July 1, 2026, growing assets from $38B to $53-54B; Stellar reported strong Q1 adjusted net income of nearly $30M, exceeding annualized projections from the original $113M FY estimate. Management expressed optimism on NIM expansion to a combined 370 bps exit rate for 2026 and mid-40s efficiency ratio post-integration, with 35% cost savings targeted from Stellar. However, they cautioned on flat loan growth this year due to integration challenges and potential post-merger runoff across deals.

• ·Stellar core system conversion completed in February 2026.
• ·Integration timelines: American Bank September 2026, Texas Partners Bank November 2026, Stellar March 8, 2027.
• ·Expect continued share buybacks given capital levels post-Stellar (25-30% cash deal).
• ·Potential 100 bps repricing on Stellar securities portfolio post-merger.

30-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 30, 2026, announcing the issuance of a press release titled 'AITX's RAD Enters Hospitality Sector with First Major Hotel Brand Order.' This represents the company's expansion into the hospitality sector via its RAD product with its inaugural major order from a hotel brand. No financial details or performance metrics were disclosed.

30-04-2026

Bed Bath & Beyond issued supplemental proxy materials responding to ISS's recommendation against the Say on Pay proposal, following a low 68.9% stockholder support in the 2025 advisory vote. The company engaged with stockholders representing 30% of outstanding shares and implemented changes for 2026 compensation, including adding revenue as a metric for bonuses and performance shares, holding target compensation flat for continuing executives (after 22%-48% grant decreases in 2025 vs. 2024), and extending vesting periods to four years. While these enhancements aim to better align pay with performance, the Compensation Committee noted limited specific feedback from stockholders on prior concerns.

• ·Independent Board members available for engagement upon request.
• ·Stockholders provided constructive feedback on incentive design and pay alignment, but no specific concerns on 2025 program.
• ·2026 performance shares vest 25% annually over four years based on goals set yearly.

30-04-2026

AIGH Capital Management LLC filed its 13F-HR on April 30, 2026, disclosing 85 holdings with a total market value of $733,217,122 as of March 31, 2026. The portfolio consists primarily of small-cap biotechnology and technology stocks, along with significant put and call options positions, including $108.5M in iShares Russell 2000 ETF puts (SOLE), $41.0M in Zoom Communications Inc Cl A calls (SOLE), and $29.1M in Select Sector SPDR Tech puts (SOLE). Top equity holdings include Tigo Energy Inc ($19.96M SOLE), Personalis Inc ($13.47M SOLE), and Abeona Therapeutics Inc ($10.12M SOLE).

• ·Report period end date: March 31, 2026
• ·Filing CIK: 0001835943
• ·Business address: 6006 Berkeley Ave., Baltimore, MD 21209
• ·Phone: 410-415-6464

30-04-2026

Trane Technologies reported Q1 2026 revenues of $4,969 million, up 6% YoY with organic growth of 3%, record bookings of $6,691 million up 27% (24% organic), and a record backlog of $10.7 billion up over 30% from year-end 2025. Adjusted continuing EPS increased 7% to $2.63, but GAAP continuing EPS declined 2% to $2.66, GAAP operating income fell 5% to $776 million with margins down 190 bps, and EMEA saw organic bookings down 9% and organic revenues down 1%. The company raised FY 2026 guidance to 9.5% reported revenue growth (7% organic) and GAAP/adjusted continuing EPS of $14.75-$14.95.

• ·Book-to-bill ratio of 135% in Q1 2026.
• ·Capital deployment YTD through April: $232M dividends, $340M M&A, $300M share repurchases.
• ·Cash balance March 31, 2026: $1,074M (up from $861M YoY).
• ·Debt balance March 31, 2026: $4,616M (down from $4,771M YoY).
• ·Working capital/revenue: 2.2% (improved 160 bps YoY).

30-04-2026

Barinthus Biotherapeutics plc has filed a DEFM14A proxy statement for its Court Meeting and General Meeting on or around May 20, 2026, to seek shareholder approval for a Scheme of Arrangement dated April 22, 2026, as part of a merger transaction under the Merger Agreement (originally dated September 29, 2025, and amended February 22, 2026) involving Beacon Topco, Inc., Cdog Merger Sub, Inc., and Clywedog Therapeutics, Inc. The resolutions authorize directors to implement the Scheme, deliver the Court order, and amend the articles of association to bind new shares to the Scheme terms. No financial metrics or performance data are disclosed in the filing.

• ·Barinthus General Meeting scheduled at 2:15 p.m. London Time on May 20, 2026, at offices of Goodwin Procter (UK) LLP, Sancroft, 10-15 Newgate Street, London EC1A 7AZ
• ·Scheme of Arrangement dated April 22, 2026
• ·Original Merger Agreement dated September 29, 2025; Amendment dated February 22, 2026
• ·Court Meeting information available on www.barinthusbio.com

30-04-2026

Molson Coors reported Q1 2026 net sales up 2.0% to $2,351.1 million driven by 3.0% favorable price/sales mix, though financial volume declined 2.9% to 14.964 million hectoliters and brand volume fell 3.1%. U.S. GAAP income before income taxes rose 24.6% to $194.7 million with underlying diluted EPS up 24.0% to $0.62; however, Americas GAAP income before taxes dipped 0.9% while EMEA&APAC underlying losses widened 47.4% in constant currency to $(32.7) million amid lower volumes across segments.

• ·Announced acquisition of Monaco Cocktails to close portfolio gap.
• ·Expanded share-repurchase program.
• ·Reaffirmed full year guidance metrics.
• ·Net cash from operations improved $93.2 million to $2.5 million.
• ·Unfavorable Midwest Premium aluminum surcharge impact of approximately $30 million.
• ·Favorable unrealized mark-to-market commodity derivatives of $70.5 million.
• ·U.S. GAAP and underlying effective tax rate increased to 23% from 21%.

30-04-2026

Cat Financial reported Q1 2026 revenues of $947 million, up 10% from $860 million in Q1 2025, driven by higher average earning assets, with profit rising 11% to $144 million and retail new business volume increasing 8% to $3.19 billion. However, net write-offs increased to $29 million from $20 million, and total assets were essentially flat at $38,163 million compared to $38,313 million at year-end 2025. Past dues improved to 1.39% from 1.58%, while the allowance for credit losses remained stable at 0.86% of receivables.

• ·Higher general, operating and administrative expenses partially offset profit before tax growth by $22 million.
• ·Favorable impact from higher average earning assets contributed $40 million to profit before tax increase.

30-04-2026

Orangekloud Technology Inc. (ORKT) filed its 20-F Annual Report on April 30, 2026, including consolidated financial statements and extensive disclosures on risks such as past losses, lack of long operating history, competition, dependence on suppliers, and potential delisting from Nasdaq. While highlighting opportunities in WhatsApp Commerce via AI Sales Ordering Solution, eMOBIQ® platform for end-to-end enterprise solutions, and partnerships with Microsoft and Acumatica, the report emphasizes numerous business, operational, and share-related risks including economic downturns, IP issues, and dual-class share structure limitations. No specific financial metrics or period-over-period comparisons are detailed in the provided sections.

• ·Company qualifies as an emerging growth company and foreign private issuer, allowing reduced reporting requirements.
• ·Risks include potential PFIC status for U.S. tax purposes and dual-class voting structure limiting influence of Class A Ordinary Shares.
• ·No immediate plans to pay dividends.

30-04-2026

Escalade Inc reported Q1 2026 net sales of $55.8M, nearly flat YoY at +0.6% from $55.5M in Q1 2025. Operating income rose sharply 60% to $5.8M, driven by a 5% decline in cost of goods sold to $38.6M, resulting in net income of $4.4M, up 67% YoY to $0.32 per share. Cash from operations improved to $6.1M from $3.8M, while cash balances grew to $13.1M from $2.2M YoY, though inventories rose 7% QoQ to $73.6M.

• ·Current portion of long-term debt increased to $16.7M as of Mar 31 2026 from $7.1M a year ago.
• ·Corporate segment reported net loss of $0.3M in Q1 2026, improved from $0.5M loss in Q1 2025.
• ·Total assets $227.6M as of Mar 31 2026, up slightly from $222.1M a year ago.
• ·Dividends declared $0.15 per share, unchanged YoY.

30-04-2026

Caterpillar Inc. reported first-quarter 2026 sales and revenues of $17.4 billion, up 22% YoY from $14.2 billion, driven by higher volume and pricing, with strong growth in Construction Industries (+38%) and Power & Energy (+22%). Profit per share rose to $5.47 (adjusted $5.54) from $4.20 ($4.25), while operating profit increased 20% to $3.085 billion; however, Resource Industries saw sales growth of only 4% and profit decline 39% to $378 million amid higher manufacturing costs including tariffs. The company deployed $5.7 billion in cash for share repurchases ($5.0 billion) and dividends ($0.7 billion), with enterprise operating cash flow at $1.9 billion.

• ·Adjusted operating profit margin declined to 18.0% from 18.3% YoY.
• ·Effective tax rate improved to 20.9% from 22.3% YoY, with a $68 million discrete tax benefit.
• ·Cat Financial past dues improved to 1.39% from 1.58%; write-offs increased to $29 million from $20 million.
• ·All Other Segment profit worsened to $(43) million from $(19) million.

30-04-2026

For the three months ended March 31, 2026, StageWise Strategies Corp. reported revenue of $25,249, up 68% YoY from $15,000, with operating expenses declining 38% to $16,693, resulting in net income of $8,556 versus a prior-year loss of $11,980. However, for the six months ended March 31, 2026, revenue fell 36% YoY to $44,467 from $69,690, leading to a net loss of $5,687 compared to a profit of $15,720, while cash and cash equivalents depleted to $0 from $4,573 at period start.

• ·1,000,000 common shares cancelled during six months ended March 31, 2026.
• ·Intangible assets decreased to $131,987 from $152,216 as of September 30, 2025.
• ·Net cash used in operating activities: $7,206 for six months ended March 31, 2026 (improved from $17,138 prior year).
• ·Loan from related parties repaid by $11,779 during six months ended March 31, 2026.

30-04-2026

L3Harris Technologies reported strong Q1 2026 results, including orders of $7.8 billion with a 1.4x book-to-bill ratio driving record backlog to $40.7 billion, revenue up 12% YoY to $5,744 million (15% organically), operating margin expansion of 120 bps to 11.4%, segment operating margin up 10 bps to 15.7%, and GAAP diluted EPS up 33% to $2.72, prompting an update to 2026 EPS guidance to $11.40-$11.60 from $11.30-$11.50. All segments showed revenue growth: Space & Mission Systems +24%, Communication & Spectrum Dominance +3%, and Missile Solutions +18%, with margin improvements across the board. However, cash used in operations increased to $(95) million from $(42) million due to timing of receipts and disbursements, resulting in free cash flow of $(187) million.

• ·Unallocated corporate items and other, net: $250 million in Q1 2026 vs $252 million in Q1 2025.
• ·Effective tax rate: 13.1% in Q1 2026 vs 15.9% in Q1 2025.
• ·2026 full-year guidance: Revenue $23B - $23.5B; Free cash flow $3.0B.
• ·Total debt reduced with long-term debt net at $9,191 million as of April 3, 2026 vs $10,443 million as of January 2, 2026.

30-04-2026

Hyatt Hotels Corporation reported strong Q1 2026 results with comparable system-wide hotels RevPAR up 5.4% YoY, all-inclusive resorts Net Package RevPAR up 7.4% YoY, gross fees up 8.6% to $333 million, and Adjusted EBITDA up 2.1% to $266 million. However, owned and leased segment Adjusted EBITDA decreased $2 million YoY after adjusting for 2025 asset sales, distribution segment Adjusted EBITDA declined due to hurricane impacts, security concerns in Mexico, and lower demand, while geopolitical issues in the Middle East negatively impacted RevPAR by 50 bps. Full-year 2026 outlook projects system-wide RevPAR growth of 2.0-4.0%, net rooms growth of 6.0-7.0%, and Adjusted EBITDA of $1,155-1,205 million, up 13-18% after adjustments.

• ·Diluted EPS $0.40 and Adjusted Diluted EPS $0.63 for Q1 2026
• ·Board declared Q2 2026 dividend of $0.15 per share, payable June 11, 2026 to shareholders of record May 29, 2026
• ·Full-year 2026 net income outlook $255-350 million
• ·Full-year 2026 gross fees outlook $1,305-1,335 million, up 9-11% vs 2025 $1,198 million
• ·Full-year 2026 capital returns to shareholders $325-375 million
• ·Conference call held April 30, 2026 at 9:00 a.m. CT

30-04-2026

Capstone Capital Management Ltd filed its 13F-HR on April 30, 2026, disclosing U.S. equity holdings as of March 31, 2026, with a total portfolio market value of $99,271,966 across 51 positions, all held with sole voting and investment discretion. Top holdings by market value include Intel Corp ($18,698,058, 423,704 shares), Synopsys Inc ($14,481,828, 36,526 shares), and Tesla Inc ($5,207,846, 14,009 shares). No prior period data is provided in the filing.

• ·Business address: Room 4701-02&13, The Center, 99 Queen's Road Central, Central, Hong Kong
• ·All positions reported with sole voting authority and no put/call options or securities loaned
• ·SEC file number: 028-26110

30-04-2026

Traws Pharma, Inc. (TRAW) filed a 10-K/A amendment on April 30, 2026. The amendment includes a note clarifying that the weighted average exercise price in the Equity Compensation Plan Information is calculated based solely on outstanding stock options, excluding shares issuable upon vesting of RSU awards which have no exercise price. No financial metrics, changes, or period comparisons are provided in the excerpt.

30-04-2026

Martin Marietta reported first-quarter 2026 revenues up 17% YoY to $1,362 million, with aggregates shipments rising 12% to a record 43.9 million tons and Adjusted EBITDA increasing 14% to $364 million, driven by organic growth and the QUIKRETE asset exchange. However, gross profit declined 2% to $310 million, aggregates gross profit per ton fell 14% to $6.56 due to purchase accounting charges and cost inflation, and net earnings dropped 24% to $79 million. The company completed the QUIKRETE exchange yielding $450 million cash, entered a definitive agreement to acquire New Frontier Materials, and reaffirmed full-year 2026 Adjusted EBITDA guidance at $2.43 billion midpoint.

• ·Cash provided by operating activities reached a first-quarter record of $227 million.
• ·Capital expenditures were $186 million in Q1 2026.
• ·Returned $251 million to shareholders via dividends and repurchases in Q1 2026.
• ·Unrestricted cash $273 million and $1.2 billion unused credit capacity as of March 31, 2026.
• ·QUIKRETE exchange included acquiring operations producing ~20 million tons annually.
• ·NFM acquisition targets >8 million tons annually in St. Louis area, expected close H2 2026.
• ·Earnings from discontinued operations included $1.4 billion after-tax gain on QUIKRETE exchange.

30-04-2026

Laureate Education reported first quarter 2026 revenue of $272.6 million, up 15% YoY on a reported basis but only 1% on a constant currency basis due to $9 million of unfavorable intra-year academic calendar timing from later semester starts. New enrollments increased 9% and total enrollments rose 6%, however operating loss widened to $(27.5) million from $(13.2) million, net loss to $(21.6) million from $(19.6) million, and Adjusted EBITDA turned to $(2.3) million from $5.4 million, also impacted by higher depreciation and amortization. The company repurchased $105 million in shares and raised full-year 2026 Adjusted EPS guidance to $2.00-$2.08 per share, reflecting 16%-21% growth.

• ·Peru new enrollments +13% and total enrollments +8% during primary intake.
• ·Mexico new and total enrollments +4% during secondary intake.
• ·Remaining stock repurchase authorization: $76 million as of March 31, 2026.
• ·FY2026 guidance: Total enrollments 516,000-521,000 (4%-5% growth); Revenues $1,890-$1,905 million (11%-12% reported growth); Adjusted EBITDA $583-$593 million (12%-14% reported growth).
• ·Basic and diluted loss per share Q1 2026: $(0.15) vs $(0.13) in Q1 2025.

30-04-2026

CCC Intelligent Solutions Holdings Inc. reported Q1 2026 revenue of $281.3 million, up 12% YoY from $251.6 million, with adjusted EBITDA increasing 21% to $120.2 million and margin expansion of approximately 300 basis points to 43%. GAAP operating income swung to $48.8 million from a $10.7 million loss, and adjusted operating income rose to $106.8 million. However, cash from operations slightly declined to $57.5 million from $58.5 million, free cash flow fell to $41.6 million from $43.6 million, and cash balances dropped to $36.9 million amid $400 million in share repurchases.

• ·Q2 2026 guidance: Revenue $283.0M to $285.0M; Adjusted EBITDA $111.0M to $113.0M.
• ·FY 2026 guidance: Revenue $1.155B to $1.163B; Adjusted EBITDA $484.0M to $490.0M.
• ·Added John Schweitzer to Board of Directors.
• ·Expanded relationship with top-five insurer (by 2024 direct premiums) via multi-year agreement for APD and AI solutions.
• ·Signed multi-year Casualty platform agreement with another top-five insurer; prior top-six insurer decision in Q4 2025.
• ·$100M remaining under $500M share repurchase authorization.
• ·Cash and cash equivalents decreased to $36.9M from $111.2M at Dec 31, 2025.

30-04-2026

Carrier Global Corporation reported Q1 2026 net sales of $5,341 million, up 2% YoY from $5,218 million, though organic sales declined 1%; Commercial HVAC orders rose 35% with data center orders up over 500%, while total company orders increased 11%. GAAP operating profit fell 59% to $259 million and adjusted operating profit dropped 30% to $594 million, with GAAP EPS down 40% to $0.28 and adjusted EPS down 12% to $0.57 amid declines in CSA Residential and China RLC. The company generated $79 million in net cash from operating activities but negative free cash flow of ($15) million, reaffirming full-year 2026 guidance of ~$22 billion in sales and adjusted EPS of ~$2.80.

• ·CSA Residential sales down ~12% YoY; Light commercial up 9%, Commercial up 1%.
• ·CSE organic sales flat; RLC up low-single digits, Commercial down mid-single digits.
• ·CSAME organic sales down 1%, driven by China RLC headwinds, offset by Commercial growth in India and Australia.
• ·CST organic sales up 5%; Container up 38%, Global Truck and Trailer down high-single digits.
• ·Full-year 2026 guidance: Organic sales flat to low-single digits; FX 1%, Net Acq/Divest (1%), ~$250M revenue headwind from Riello exit; Adjusted Op Profit ~$3.4B; Adjusted EPS ~$2.80; FCF ~$2B.
• ·Riello divestiture expected to close by end of Q2 2026.

30-04-2026

Garrett Motion reported Q1 2026 net sales of $985 million, up 12% reported (6% constant currency) from $878 million in Q1 2025, with Adjusted EBIT of $151 million (15.3% margin) up from $131 million (14.9% margin) and Adjusted free cash flow of $49 million up from $36 million. However, gross profit margin declined slightly to 19.9% from 20.4%, and available liquidity decreased to $772 million from $807 million at year-end 2025. The company raised its full-year 2026 outlook for net sales to $3.6-3.9 billion (from $3.6-3.8 billion), declared a $0.08 per share dividend, and repurchased $87 million in shares.

• ·Board declared cash dividend of $0.08 per share, payable June 15, 2026 to shareholders of record June 1, 2026.
• ·Remaining share repurchase capacity of $163 million as of March 31, 2026.
• ·Full-year 2026 outlook raised: Adjusted EBIT $520-600M (prior $520-570M), Adjusted FCF $355-475M (prior $355-455M).

30-04-2026

Hilton Grand Vacations reported first quarter 2026 total revenues of $1.285 billion, up approximately 11.9% YoY from $1.148 billion, with Adjusted EBITDA attributable to stockholders of $249 million, up 38.3% YoY from $180 million, driven by Real Estate Sales and Financing segment revenues of $754 million (up 16.9% YoY) and Adjusted EBITDA margin expansion to 28.0%. However, total contract sales were nearly flat at $719 million (down $2 million YoY), VPG declined 8.1% YoY despite an 8.5% increase in tours, and Resort Operations and Club Management Adjusted EBITDA fell to $128 million with margin contraction to 31.8% from 34.0%. The company raised full-year 2026 Adjusted EBITDA guidance (excluding deferrals) to $1.225-$1.265 billion, repurchased 3.3 million shares for $150 million, and announced subsequent events including a $500 million securitization and $129 million acquisition.

• ·Net construction deferral of $18 million in Q1 2026 (vs $68 million in Q1 2025).
• ·Total net leverage 3.9x on trailing 12-month basis as of March 31, 2026.
• ·Fee-for-service contract sales increased to 16.7% of total contract sales from 15.4% YoY.
• ·Proposed disposition of certain property interests expected to close by end of Q3 2026.

30-04-2026

Phathom Pharmaceuticals reported Q1 2026 product revenue of $58.3M, up 104% YoY from $28.5M, with gross profit rising 87% to $46.3M; net loss narrowed to $30.4M from $94.3M YoY, aided by 43% lower SG&A expenses. Cash and equivalents increased 39% QoQ to $180.9M, bolstered by $122M net proceeds from a public offering and new debt issuance, though offset by $229M debt repayment. However, the company remains unprofitable with operating loss of $15.5M, high total liabilities of $642.1M including $163.7M long-term debt and $347.9M revenue interest financing, and stockholders' deficit of $337.0M.

• ·Accounts receivable, net increased to $80.7M from $78.1M QoQ.
• ·Total inventory stable at $25.6M vs $26.3M QoQ.
• ·Weighted-average shares outstanding: 82,050,618 for Q1 2026 vs 71,969,411 for Q1 2025.
• ·Interest paid: $4.9M in Q1 2026 vs $5.2M in Q1 2025.

30-04-2026

Baxter International Inc. reported first-quarter 2026 sales from continuing operations of $2.7 billion, increasing 3% on a reported basis but declining 1% organically, with U.S. sales down 4% to $1.44 billion while international sales rose 12% reported (3% organic) to $1.27 billion. Segment results were mixed: Medical Products & Therapies sales of $1.3 billion declined 2% organically, Healthcare Systems & Technologies at $705 million were flat reported (down 2% organic), and Pharmaceuticals grew 7% reported (1% organic) to $621 million; adjusted diluted EPS from continuing operations was $0.36, down 35% YoY. The company reiterated its full-year 2026 outlook for flat to 1% reported sales growth, approximately flat organic growth, and adjusted EPS of $1.85 to $2.05.

• ·GAAP diluted EPS (loss) from continuing operations of ($0.03); net income (loss) from continuing operations ($17) million.
• ·Full-year 2026 outlook: reported sales growth flat to 1%, organic sales growth approximately flat, adjusted EPS $1.85 to $2.05.
• ·Kidney Care business divested in January 2025, reported as discontinued operations.
• ·Upcoming investor events: BofA Securities 2026 Health Care Conference (May 13, 2026), Goldman Sachs 47th Annual Global Healthcare Conference (June 9, 2026).

30-04-2026

Butterfly Network reported first quarter 2026 revenue of $26.5 million, up 25% YoY from $21.2 million, exceeding consensus estimates, driven by U.S. revenue of $21.4 million (+25%) and international revenue of $5.2 million (+23%). Gross margin expanded 590 basis points to 68.9%, and Adjusted EBITDA loss improved 32% YoY to $6.1 million, though operating expenses increased 1% to $32.2 million amid ongoing net losses of $12.7 million. The company reaffirmed FY2026 revenue guidance of $117-121 million (20-24% growth at midpoint) and Adjusted EBITDA loss of $21-25 million, with Q2 guidance for revenue of $27-31 million (~24% YoY at midpoint) and Adjusted EBITDA loss of $6-8 million.

• ·Signed ninth company to Butterfly Embedded™ portfolio as of April 2026.
• ·Butterfly Garden Ecosystem added two new partners, totaling 30.
• ·Progressing toward first Home & Community Care commercial agreement in H1 2026, with initial deployment in Q3 2026.
• ·Q1 2026 EPS of $(0.05) improved from $(0.06) in Q1 2025; Adjusted EPS $(0.03) from $(0.04).